Finance & Banking
Coinbase Global Stock Rises. The Company Is Set to Join the S&P 500

Shares of Coinbase World (COIN) jumped in after-hours buying and selling Monday on the information that the crypto alternate could be added to the S&P 500.
The inventory, which had risen roughly 4% throughout an upbeat common session pushed by trade-related optimism, was lately up greater than 9% in late motion, indicating a transfer towards share costs final seen in January. Bitcoin, the main cryptocurrency, lately modified arms round $102,980.
“Thanks to everybody who made it doable for a crypto firm to affix the S&P 500 for the primary time in historical past,” Coinbase mentioned in a message on the social community X.
Coinbase will exchange Uncover Monetary Companies (DFS) within the benchmark index earlier than buying and selling opens subsequent Monday, based on S&P Dow Jones Indices. Uncover is ready to merge with Capital One Monetary (COF) after their deal received the regulatory go-ahead in April.
Shares of Coinbase are down about 17% in 2025 by Monday’s shut. The corporate has a market cap of roughly $50.8 billion, based on Seen Alpha information.
Finance & Banking
Micron Technology to Spend $200B to Boost Domestic Chip Production

Key Takeaways
- Micron Know-how on Thursday introduced a $200 billion funding to spice up semiconductor manufacturing within the U.S.
- Roughly $150 billion is scheduled for use for fabs in three states and superior high-bandwith reminiscence packaging capabilities, and $50 billion for analysis and growth.
- Micron has secured federal, state, and native funding, which incorporates as a lot as $6.4 billion from the CHIPS and Science Act.
Micron Know-how (MU) on Thursday grew to become the newest main company to announce plans to develop home manufacturing following President Donald Trump’s name for corporations to spice up American manufacturing.
The chipmaker and the Trump administration stated Micron will increase its U.S. investments to about $150 billion in reminiscence manufacturing and $50 billion in research and development (R&D).
Micron defined that a lot of the cash could be used for “two modern high-volume fabs in Idaho, as much as 4 modern high-volume fabs in New York, the growth and modernization of its current manufacturing fab in Virginia,” in addition to superior high-bandwith reminiscence (HBM) packaging capabilities.
The corporate famous that it has already acquired federal, state, and native funding for the Idaho, New York, and Virginia fab work, together with up to $6.4 billion from the CHIPS and Science Act. Micron added it expects the entire investments will probably be eligible for federal Superior Manufacturing Funding Credit score (AMIC).
CEO Sanjay Mehrotra argued that this growth “will reinforce America’s technological management, create tens of hundreds of American jobs throughout the semiconductor ecosystem and safe a home provide of semiconductors—crucial to financial and nationwide safety.”
GM, TSMC, Apple Amongst Others to Enhance US Manufacturing
This week, Normal Motors (GM) introduced it could spend $4 billion to extend automobile manufacturing at three U.S. crops. Earlier this 12 months, chipmaking large Taiwan Semiconductor Manufacturing Co. (TSM) stated it deliberate to speculate $100 billion in U.S.-based chip manufacturing amenities, and Apple (AAPL) introduced plans to spend more than $500 billion domestically over the subsequent 4 years.
Shares of Micron Know-how had been little modified as we speak however are up 37% this 12 months, buying and selling at their highest stage since final July.
TradingView
Finance & Banking
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments

Key Takeaways
- BioNTech is shopping for fellow German agency CureVac for roughly $1.25 billion because the COVID-19 vaccine maker strikes to develop into most cancers remedies.
- For every CureVac share they personal, buyers will get about $5.46 value of BioNTech American Depositary Shares.
- CureVac is growing most cancers medicines utilizing the identical mRNA expertise that BioNTech makes use of for its COVID-19 shot.
CureVac (CVAC) shares skyrocketed 37% Thursday when the biotech firm agreed to be purchased by COVID-19 vaccine maker and fellow German agency BioNTech (BNTX) in an all-stock deal valued at about $1.25 billion. The acquisition boosts BioNTech’s transfer into producing new most cancers remedies.
CureVac mentioned its buyers will obtain roughly $5.46 value of BioNTech American Depositary Shares for every CureVac share they personal. {That a} 34% premium to yesterday’s closing value.
The corporate famous it’s “growing a novel class of transformative medicines in oncology and infectious ailments primarily based on messenger ribonucleic acid (“mRNA”).” BioNTech’s COVID-19 shot can also be mRNA-based.
BioNTech co-founder and CEO Dr. Ugur Sahin mentioned the deal is aimed toward “advancing the event of revolutionary and transformative most cancers remedies and establishing new requirements of look after numerous varieties of most cancers within the coming years.”
The transaction is predicted to shut this yr and would see CureVac’s working subsidiary turn into an entirely owned subsidiary of BioNTech.
Shares of CureVac soared to their highest degree since December 2023. U.S.-listed shares of BioNTech had been little modified and stay down practically 8% year-to-date.
TradingView
Finance & Banking
GameStop Stock Extends Post-Earnings Decline on $1.75B Convertible Note Offering

Key Takeaways
- GameStop shares are dropping 17% in premarket buying and selling Thursday, extending a post-earnings slide.
- After the bell Wednesday, the video-game retailer introduced a $1.75 billion convertible word providing. Shares fell greater than 5% yesterday after GameStop reported a 17% year-over-year decline in first-quarter gross sales.
- The retailer stated final month that it had purchased over 4,700 bitcoin.
GameStop (GME) shares are dropping 17% in premarket buying and selling Thursday, a day after the video-game retailer announced a new fundraising effort.
The corporate late yesterday stated it was planning to supply $1.75 billion in convertible notes, with one other $250 million open to those that purchase in first. The announcement got here a day after GameStop reported a 17% year-over-year decline in first-quarter gross sales, which induced shares to fall greater than 5% in Wednesday buying and selling.
The brand new convertible word providing aligns with the retailer’s previously stated plans to boost new cash to permit it to purchase bitcoin, after adding the cryptocurrency to its company funding coverage in March.
Final month, GameStop disclosed that it had purchased 4,710 bitcoin, value barely greater than $500 million on the cryptocurrency’s present value of roughly $107,000. GameStop stated it plans to make use of the brand new funds for “basic company functions, together with making investments in a fashion in line with GameStop’s Funding Coverage and potential acquisitions.”
GameStop shares entered Thursday down about 9% for the reason that begin of the yr.
-
Travel2 weeks ago
16 Things Foreigners Notice Most About People from Michigan
-
Travel3 weeks ago
15 High-Paying Careers in Indiana
-
Life Style2 weeks ago
5 Steps to Help You Move On and Feel Less Pain
-
Business2 weeks ago
Salesforce Is Cutting Back on Hiring Engineers Thanks to AI
-
Technology3 weeks ago
Landa promised real estate investing for $5. Now it’s gone dark.
-
Technology3 weeks ago
What you won’t want to miss at the 20th Disrupt in October
-
Crypto News2 weeks ago
Grinex’s reach expands to $1.66B despite history of sanctions
-
News2 weeks ago
Webb Reveals that Europa’s Surface is Constantly Changing